Australis Capital

Las Vegas, United States

Australis Capital is a pharmaceutical public company that develops and helps grow the cannabis industry to meet the growing market demand.

$7.9M raised

Feb 2022

Post-IPO Equity

Cannabis Financial Services Health Care Logistics Pharmaceutical

Top Investors

LDA Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Australis Capital

How much funding has Australis Capital raised?

Australis Capital has raised $7.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2022.

Who are Australis Capital's investors?

Australis Capital's investors include LDA Capital.

Where is Australis Capital headquartered?

Australis Capital is headquartered in Las Vegas, United States.

What does Australis Capital do?

Australis Capital is a pharmaceutical public company that develops and helps grow the cannabis industry to meet the growing market demand.

What stage is Australis Capital at?

Australis Capital is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 14, 2022.

MLA

"Australis Capital — Funding & Investors." VCBacked, February 14, 2022, https://www.vcbacked.co/company/australis-capital. Accessed July 2, 2026.

APA

VCBacked. (2022). Australis Capital — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/australis-capital

Wikipedia (cite web)

{{cite web |title=Australis Capital — Funding & Investors |url=https://www.vcbacked.co/company/australis-capital |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 14, 2022.

Similar Companies in Cannabis

View all

Gaia's Farming Co.

London$638K

Cannabinoid API Solutions